Counterfeit Ozempic-labelled pens are being offered in Australia.
The Therapeutic Items Administration (TGA) and the Australian Border Drive (ABF) have detected the faux Ozempic-labelled pens.
The TGA is warning individuals to search for spelling errors, instruction leaflets not in English, unsealed packaging, or modifications in drugs measurement, form, or look. These are indicators that the medication has not been produced by the unique producer or is being illegally offered within the mistaken market.
The 2 merchandise which have prompted the alert each look like relabelled insulin pens. The top ap is blue (not gray), the dosage barrel is in a special place, the sticker isn’t adhering correctly to the pen, and the packaging is poor high quality.
There has already been a life-threatening incident in Australia with an individual utilizing a faux pen labelled as Ozempic which contained insulin. This pen was purchased abroad. Unintended use of insulin could cause dangerously low life-threatening blood glucose ranges.
The batch numbers labelled on the pens - NPSG234 detected by ABF and JS7A925 from the opposed occasion – have been confirmed as not real batch numbers by Novo Nordisk, the producer of Ozempic.
The ABF stated the merchandise have been bought on-line from an abroad web site and imported beneath the private importation scheme.
